Robeco Institutional Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Robeco Institutional Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$417M	Buy	7,244,630 +510,890	+8%	+$29.3M	0.51%	36
2026 Q1	$408M	Buy	6,733,740 +28,933	+0.4%	+$1.69M	0.58%	31
2025 Q4	$362M	Sell	6,704,807 -105,825	-2%	-$5.09M	0.52%	34
2025 Q3	$307M	Buy	6,810,632 +409,231	+6%	+$19.1M	0.45%	42
2025 Q2	$296M	Buy	6,401,401 +2,014,075	+46%	+$98.9M	0.48%	36
2025 Q1	$268M	Buy	4,387,326 +8,879	+0.2%	+$518K	0.52%	43
2024 Q4	$248M	Sell	4,378,447 -31,624	-0.7%	-$1.77M	0.47%	44
2024 Q3	$228M	Buy	4,410,071 +109,503	+3%	+$5.14M	0.45%	47
2024 Q2	$179M	Buy	4,300,568 +1,193,731	+38%	+$53.4M	0.38%	57
2024 Q1	$168M	Sell	3,106,837 -812,697	-21%	-$41.4M	0.37%	59
2023 Q4	$201M	Sell	3,919,534 -9,125	-0.2%	-$479K	0.49%	51
2023 Q3	$228M	Sell	3,928,659 -21,866	-0.6%	-$1.34M	0.61%	35
2023 Q2	$253M	Sell	3,950,525 -191,681	-5%	-$12.9M	0.66%	26
2023 Q1	$287M	Buy	4,142,206 +150,126	+4%	+$10.6M	0.78%	22
2022 Q4	$287M	Sell	3,992,080 -101,451	-2%	-$7.65M	0.83%	17
2022 Q3	$291M	Buy	4,093,531 +1,200,434	+41%	+$87.1M	0.94%	15
2022 Q2	$223M	Buy	2,893,097 +476,440	+20%	+$36.3M	0.69%	29
2022 Q1	$176M	Sell	2,416,657 -31,133	-1%	-$2.09M	0.42%	61
2021 Q4	$153M	Buy	2,447,790 +82,857	+4%	+$4.86M	0.32%	82
2021 Q3	$140M	Buy	2,364,933 +231,523	+11%	+$15.2M	0.31%	84
2021 Q2	$143M	Buy	2,133,410 +818,609	+62%	+$53.4M	0.32%	83
2021 Q1	$83M	Buy	1,314,801 +602,256	+85%	+$37.5M	0.2%	127
2020 Q4	$44.2M	Sell	712,545 -174,867	-20%	-$10.8M	0.12%	199
2020 Q3	$53.5M	Buy	887,412 +36,795	+4%	+$2.21M	0.17%	146
2020 Q2	$50M	Sell	850,617 -19,222	-2%	-$1.15M	0.17%	146
2020 Q1	$48.5M	Buy	869,839 +71,029	+9%	+$4.34M	0.19%	134
2019 Q4	$51.3M	Buy	798,810 +143,204	+22%	+$8.2M	0.16%	174
2019 Q3	$33.2M	Sell	655,606 -2,143	-0.3%	-$101K	0.12%	228
2019 Q2	$29.8M	Sell	657,749 -7,156	-1%	-$333K	0.11%	255
2019 Q1	$31.7M	Buy	664,905 +24,465	+4%	+$1.22M	0.12%	241
2018 Q4	$33.2M	Buy	640,440 +85,121	+15%	+$4.57M	0.15%	193
2018 Q3	$34.5M	Buy	555,319 +91,378	+20%	+$5.42M	0.14%	199
2018 Q2	$25.7M	Buy	463,941 +44,562	+11%	+$2.41M	0.12%	222
2018 Q1	$26.5M	Buy	419,379 +68,388	+19%	+$4.4M	0.12%	215
2017 Q4	$21.5M	Buy	350,991 +253,871	+261%	+$15.9M	0.11%	228
2017 Q3	$6.19M	Sell	97,120 -6,812	-7%	-$398K	0.04%	403
2017 Q2	$5.79M	Buy	103,932 +27,041	+35%	+$1.47M	0.04%	407
2017 Q1	$4.18M	Buy	76,891 +21,098	+38%	+$1.16M	0.03%	455
2016 Q4	$3.26M	Sell	55,793 -582,675	-91%	-$31.9M	0.03%	436
2016 Q3	$34.4M	Sell	638,468 -65,300	-9%	-$4.19M	0.25%	122
2016 Q2	$51.8M	Buy	703,768 +233,106	+50%	+$16.5M	0.39%	83
2016 Q1	$30.1M	Buy	470,662 +12,729	+3%	+$803K	0.24%	128
2015 Q4	$31.5M	Buy	457,933 +4,631	+1%	+$306K	0.27%	124
2015 Q3	$26.8M	Buy	453,302 +3,988	+0.9%	+$253K	0.2%	149
2015 Q2	$29.9M	Buy	449,314 +999	+0.2%	+$65.8K	0.23%	133
2015 Q1	$28.9M	Sell	448,315 -4,563	-1%	-$286K	0.22%	134
2014 Q4	$26.7M	Sell	452,878 -58,844	-11%	-$3.32M	0.19%	143
2014 Q3	$26.2M	Buy	511,722 +7,566	+2%	+$378K	0.19%	133
2014 Q2	$24.5M	Buy	504,156 +11,936	+2%	+$588K	0.18%	142
2014 Q1	$25.6M	Sell	492,220 -24,349	-5%	-$1.3M	0.2%	121
2013 Q4	$27.5M	Buy	516,569 +3,928	+0.8%	+$200K	0.23%	103
2013 Q3	$23.7M	Sell	512,641 -18,251	-3%	-$801K	0.23%	93
2013 Q2	$23.7M	Buy	+530,892	New	+$23M	0.24%	87

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Robeco Institutional Asset Management's BMY Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q2 2026, buying an estimated $29.3M and bringing the position to 7,244,630 shares worth $417M. The position accounts for 0.51% of the portfolio, ranked #36.

Robeco Institutional Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Robeco Institutional Asset Management held 7,244,630 shares of Bristol-Myers Squibb worth $417M as of Q2 2026.
Robeco Institutional Asset Management bought 510,890 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.3M.
Bristol-Myers Squibb made up 0.51% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #36 holding.
Robeco Institutional Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.